SCHEMBL3678860

SCHEMBL3678860

O=C(NC[C@H]1CN(c2ccc(N3CCCC(O)C3=O)cc2F)C(=O)O1)Oc1ccc(Cl)s1

nearest known ligand 0.60

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
F10 P00742 19/20 0.60
MAOB P27338 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3687020 0.91 F10 (0.58) F10MAOB
SCHEMBL2991837 0.88 F10 (0.76) F10
SCHEMBL3684431 0.87 F10 (0.54) F10
SCHEMBL3678642 0.86 F10 (0.60) F10
SCHEMBL3262953 0.84 F10 (0.74) F10MAOB
SCHEMBL3690092 0.82 F10 (0.60) F10
SCHEMBL3670726 0.82 F10 (0.49) F10
SCHEMBL16493912 0.80 F10 (0.55) F10
SCHEMBL2994190 0.79 F10 (0.74) F10
SCHEMBL3677147 0.79 F10 (0.56) F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2167495-A1 SUBSTITUTED OXAZOLIDINONES AND THE USE THEREOF Bayer Schering Pharma AG (DE) 2010-03-31 EP disclosed
WO-2008155034-A1 SUBSTITUTED OXAZOLIDINONES AND THE USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-12-24 WO disclosed